News -

Isofol presents at the Stockholm Corporate Finance Life Science Day

Isofol’s Chief Scientific Officer, Anders Vedin presented at the Stockholm Corporate Finance Life Science Day 2015 at Operaterrassen in Stockholm.

To see the presentation click here.


For more information, please contact:

Anders Rabbe, CEO,

E‐mail: anders.rabbe@isofolmedical.com

Phone: +46 (0)707 646 500

Anders Vedin

Chief Scientific Officer

Email: anders.vedin@isofolmedical.com

Phone: +46 (0)708 761 570

Related links

Topics

  • Medicine, Pharmaceuticals

Categories

  • stockholm corporate finance
  • financial hearings
  • isofol
  • modufolin
  • colorectal cancer
  • rectal cancer
  • hdmx
  • rescue treatment
  • leucovorin
  • levoleucovorin
  • merck & cie